Summary

Acknowledgement

We would like to acknowledge the individuals and institutions that have provided data for this collection:

• Angelica Trejo, Han Chen, Kenyi Donoso, Nilanjan Mukherjee, Vishal Venkataraaman, and Gustavo Vazquez (Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA) for excellent technical assistance.
• Sandrine Ruppen, Carmen Cardozo, and Dr. José Galván (Institute of Pathology, University of Bern, Switzerland) for help with creating the TMAs.
• Dr. Anna Seigal (Mathematical Institute, University of Oxford, Oxford, UK University) for helpful discussions regarding tensor decomposition.
• Dr. Julian Schardt (Department of Medical Oncology, Inselspital, University Hospital Bern, Switzerland) for helping obtain patient clinical information.
• Prof. Paul Bollyky (Department of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA) for providing the biotinylated VG1 hyaluronan-detection reagent.
• The patients for their consent to use their tissues for research.
• Dr. Sizun Jiang and Dr. Xavier Rovira-Clavé (Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA) for critical comments on the manuscript.

We would also like to acknowledge the following institutions and companies for their grants and awards given for this collection:

• US National Institutes of Health grants and sub awards: (2U19AI057229-16) (5P01HL10879707) (5R01GM10983604) (5R33CA18365403) (5U01AI101984-07) (5UH2AR06767604) (5R01CA19665703) (5U54CA20997103) (5F99CA212231-02) (1F32CA233203-01) (5U01AI140498-02) (1U54HG010426-01) (5U19AI100627-07) (1R01HL120724-01A1) (R33CA183692) (R01HL128173-04) (5P01AI131374-02) (5UG3DK114937-02) (1U19AI135976-01) (IDIQ17X149) (1U2CCA233238-01) (1U2CCA233195-01)
• The Department of Defense: (W81XWH-14-1-0180 and W81XWH-12-1-0591)
• The Food and Drug Administration: (HHSF223201610018C and DSTL/AGR/00980/01)
• Cancer Research UK: (C27165/A29073)
• The Bill and Melinda Gates Foundation: (OPP1113682)
• The Cancer Research Institute
• The Parker Institute for Cancer Immunotherapy
• The Kenneth Rainin Foundation: (2018-575)
• The Silicon Valley Community Foundation: (2017-175329 and 2017-177799-5022)
• The Beckman Center for Molecular and Genetic Medicine
• Juno Therapeutics, Inc. : (122401)
• Pfizer, Inc. : (123214)
• Celgene, Inc. : (133826 and 134073)
• Vaxart, Inc. : (137364)
• The Rachford & Carlotta A. Harris Endowed Chair (G.P.N.)
• C.M.S. was supported by an Advanced Postdoc Mobility Fellowship from the Swiss National Science Foundation (P300PB_171189 and P400PM_183915), and an International Award for Research in Leukemia from the Lady Tata Memorial Trust, London, UK.
• D.J.P. was supported by an NIH T32 Fellowship through Stanford’s Department of Epithelial Biology (AR007422), an NIH F32 Fellowship (CA233203), a Stanford Dean’s Postdoctoral Fellowship, and Stanford’s Dermatology Department.
• S.S.B. was supported by a Bio-X Stanford Interdisciplinary Graduate Fellowship and Stanford’s Bioengineering Department.
• G.L.B was supported by an NIH T32 Fellowship through Stanford’s Molecular and Cellular Immunobiology Program (5T32AI007290-34).

Data available for download at the end of August 2020.